DK2872497T4 - Chromanyl-derivater til behandling af mitokondriel sygdom - Google Patents
Chromanyl-derivater til behandling af mitokondriel sygdom Download PDFInfo
- Publication number
- DK2872497T4 DK2872497T4 DK13759838T DK13759838T DK2872497T4 DK 2872497 T4 DK2872497 T4 DK 2872497T4 DK 13759838 T DK13759838 T DK 13759838T DK 13759838 T DK13759838 T DK 13759838T DK 2872497 T4 DK2872497 T4 DK 2872497T4
- Authority
- DK
- Denmark
- Prior art keywords
- mitocondal
- disease
- treatment
- chromanyl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261670644P | 2012-07-12 | 2012-07-12 | |
| EP12176128 | 2012-07-12 | ||
| PCT/NL2013/050528 WO2014011047A1 (en) | 2012-07-12 | 2013-07-12 | Chromanyl derivatives for treating mitochondrial disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK2872497T3 DK2872497T3 (da) | 2017-04-24 |
| DK2872497T4 true DK2872497T4 (da) | 2019-11-25 |
Family
ID=49916367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13759838T DK2872497T4 (da) | 2012-07-12 | 2013-07-12 | Chromanyl-derivater til behandling af mitokondriel sygdom |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2872497B2 (da) |
| JP (1) | JP6292721B2 (da) |
| KR (1) | KR102137450B1 (da) |
| CN (1) | CN104662011B (da) |
| AU (1) | AU2013287347B2 (da) |
| CA (1) | CA2878567C (da) |
| DK (1) | DK2872497T4 (da) |
| ES (1) | ES2622190T5 (da) |
| HU (1) | HUE033757T2 (da) |
| LT (1) | LT2872497T (da) |
| PL (1) | PL2872497T5 (da) |
| PT (1) | PT2872497T (da) |
| RS (1) | RS55813B2 (da) |
| SI (1) | SI2872497T2 (da) |
| WO (1) | WO2014011047A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11491480B2 (en) | 2014-06-13 | 2022-11-08 | Children's Medical Center Corporation | Products and methods to isolate mitochondria |
| CN107660148B (zh) * | 2015-05-22 | 2021-03-09 | 萨尔法泰克有限公司 | 用于预防或治疗器官损伤的化合物 |
| WO2016190852A1 (en) * | 2015-05-26 | 2016-12-01 | Stealth Peptides International, Inc. | Therapeutic compositions including chromanyl compounds, variants and analogues thereof, and uses thereof |
| US10815211B2 (en) | 2015-10-08 | 2020-10-27 | Khondrion Ip B.V. | Compounds for treating mitochondrial disease |
| WO2017124037A1 (en) * | 2016-01-15 | 2017-07-20 | The Children's Medical Center Corporation | Therapeutic use of mitochondria and combined mitochondrial agents |
| KR101816277B1 (ko) * | 2016-10-06 | 2018-01-08 | 가천대학교 산학협력단 | 8-옥소-데옥시구아노신(8-oxo-2'-deoxyguanosine) 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 각막 손상 치료용 약학적 조성물 |
| CA3058033A1 (en) * | 2017-04-05 | 2018-10-11 | Khondrion Ip B.V. | Treatment of mitochondrial diseases |
| WO2019101826A1 (en) | 2017-11-22 | 2019-05-31 | Khondrion Ip B.V. | Compounds as mpges-1 inhibitors |
| AU2018371152B2 (en) * | 2017-11-22 | 2024-02-08 | Khondrion Ip B.V. | Novel compounds for use in treating depression and migraine |
| CA3127654A1 (en) | 2019-01-25 | 2020-07-30 | Universitat Autonoma De Barcelona | Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases |
| KR20220078644A (ko) * | 2019-10-04 | 2022-06-10 | 스텔스 바이오테라퓨틱스 인코포레이티드 | 미토콘드리아 질환 치료를 위한 바티퀴논의 퀴논-, 히드로퀴논- 및 나프토퀴논-유사체 |
| NL2024431B1 (en) | 2019-12-11 | 2021-09-07 | Sulfateq Bv | Compounds for treatment of alzheimer’s disease |
| NL2025730B1 (en) | 2020-06-02 | 2022-01-20 | Sulfateq Bv | Compounds for treatment of sepsis |
| NL2026511B1 (en) | 2020-09-21 | 2022-05-24 | Sulfateq Bv | Compounds for treatment of heart failure |
| NL2031091B1 (en) | 2022-02-28 | 2023-09-07 | Sulfateq Bv | Chromanol compounds for treatment or prophylaxis of ageing and ageing-associated disorders |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1338012C (en) | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
| JPH02250831A (ja) * | 1989-03-23 | 1990-10-08 | Kuraray Co Ltd | ３，４―ジヒドロ―２ｈ―ベンゾピラン誘導体及びそれを有効成分とする抗消化性潰瘍剤 |
| FR2676056B1 (fr) | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JP3093170B2 (ja) * | 1996-09-19 | 2000-10-03 | 株式会社ジャパンエナジー | ヒドロキノン誘導体及びその医薬用途 |
| FR2761066B1 (fr) * | 1997-03-24 | 2000-11-24 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| FR2764889B1 (fr) * | 1997-06-20 | 2000-09-01 | Sod Conseils Rech Applic | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| JPH11106371A (ja) * | 1997-07-04 | 1999-04-20 | Nisshin Flour Milling Co Ltd | アシルヒドラゾン誘導体 |
| AR019190A1 (es) * | 1998-07-08 | 2001-12-26 | Sod Conseils Rech Applic | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos |
| EP1101759A4 (en) * | 1998-07-31 | 2001-12-12 | Nippon Soda Co | PHENYLAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICATIONS FOR HYPERLIPEMY |
| FR2783519B1 (fr) * | 1998-09-23 | 2003-01-24 | Sod Conseils Rech Applic | Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant |
| AU2001262200A1 (en) * | 2000-04-25 | 2001-11-07 | Schering Aktiengesellschaft | Benzoxazine derivatives and benzothiazine derivatives having nos-inhibitory and antioxidant properties |
| GR1003725B (el) | 2000-07-12 | 2001-11-27 | Νεες ενωσεις με συνδυασμενη αντιοξειδωτικη και αντιαρρυθμικη δραση | |
| JP2002047272A (ja) * | 2000-07-26 | 2002-02-12 | Dai Ichi Seiyaku Co Ltd | ポリアミンアミド誘導体 |
| NZ513547A (en) | 2001-08-13 | 2002-09-27 | Antipodean Biotechnology Ltd | Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone) |
| JP2003212872A (ja) * | 2002-01-23 | 2003-07-30 | Japan Energy Corp | 新規クロマン誘導体及びその医薬用途 |
| GB0204232D0 (en) | 2002-02-22 | 2002-04-10 | Isis Innovation | Assay |
| CA2534263A1 (en) * | 2003-08-01 | 2005-02-10 | Nippon Soda Co., Ltd. | Phenylazole compounds, production process and antioxidants |
| WO2005032544A1 (en) | 2003-09-19 | 2005-04-14 | Galileo Pharmaceuticals, Inc. | Treatment of mitochondrial diseases |
| JP2008019188A (ja) * | 2006-07-11 | 2008-01-31 | Hamari Chemicals Ltd | 新規カルノシン誘導体及び組成物 |
| EA038941B1 (ru) * | 2007-11-06 | 2021-11-12 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ |
| EP2601168A4 (en) | 2010-08-06 | 2013-12-04 | Ampere Life Sciences Inc | TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K |
| BR112013002877A2 (pt) | 2010-08-06 | 2016-05-31 | Edison Pharmaceuticals Inc | tratamento de doenças mitocondriais com naftoquinonas |
| NL2010010C2 (en) | 2012-12-19 | 2014-06-23 | Sulfateq B V | Compounds for protection of cells. |
-
2013
- 2013-07-12 HU HUE13759838A patent/HUE033757T2/en unknown
- 2013-07-12 EP EP13759838.9A patent/EP2872497B2/en active Active
- 2013-07-12 CN CN201380037183.8A patent/CN104662011B/zh active Active
- 2013-07-12 PT PT137598389T patent/PT2872497T/pt unknown
- 2013-07-12 JP JP2015521570A patent/JP6292721B2/ja active Active
- 2013-07-12 DK DK13759838T patent/DK2872497T4/da active
- 2013-07-12 WO PCT/NL2013/050528 patent/WO2014011047A1/en active Application Filing
- 2013-07-12 KR KR1020157000618A patent/KR102137450B1/ko active IP Right Grant
- 2013-07-12 ES ES13759838T patent/ES2622190T5/es active Active
- 2013-07-12 LT LTEP13759838.9T patent/LT2872497T/lt unknown
- 2013-07-12 AU AU2013287347A patent/AU2013287347B2/en active Active
- 2013-07-12 RS RS20170348A patent/RS55813B2/sr unknown
- 2013-07-12 SI SI201330603T patent/SI2872497T2/sl unknown
- 2013-07-12 CA CA2878567A patent/CA2878567C/en active Active
- 2013-07-12 PL PL13759838T patent/PL2872497T5/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20150036035A (ko) | 2015-04-07 |
| LT2872497T (lt) | 2017-04-25 |
| CN104662011B (zh) | 2017-09-29 |
| PL2872497T3 (pl) | 2017-07-31 |
| SI2872497T2 (sl) | 2019-12-31 |
| HUE033757T2 (en) | 2017-12-28 |
| DK2872497T3 (da) | 2017-04-24 |
| ES2622190T5 (es) | 2020-04-23 |
| ES2622190T3 (es) | 2017-07-05 |
| PT2872497T (pt) | 2017-04-24 |
| EP2872497B1 (en) | 2017-03-08 |
| KR102137450B1 (ko) | 2020-07-27 |
| EP2872497B2 (en) | 2019-10-09 |
| RS55813B1 (sr) | 2017-08-31 |
| CA2878567C (en) | 2021-02-23 |
| JP2015522067A (ja) | 2015-08-03 |
| WO2014011047A1 (en) | 2014-01-16 |
| AU2013287347B2 (en) | 2017-11-30 |
| PL2872497T5 (pl) | 2020-02-28 |
| AU2013287347A1 (en) | 2015-01-22 |
| EP2872497A1 (en) | 2015-05-20 |
| JP6292721B2 (ja) | 2018-03-14 |
| CA2878567A1 (en) | 2014-01-16 |
| SI2872497T1 (sl) | 2017-08-31 |
| CN104662011A (zh) | 2015-05-27 |
| RS55813B2 (sr) | 2019-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2785706I2 (lt) | Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui | |
| CY2019033I1 (el) | Μακροκυκλικα παραγωγα για την αγωγη υπερπλαστικων παθησεων | |
| DK2872497T4 (da) | Chromanyl-derivater til behandling af mitokondriel sygdom | |
| SMT201700065B (it) | Derivato piridonico | |
| DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
| DK2895156T3 (da) | Fremgangsmåde til fremstilling af terapeutiske nanopartikler | |
| DK2885010T3 (da) | Fremgangsmåder til behandling med tauopati | |
| DK2818482T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2824114T3 (da) | Farmaceutisk sammensætning til behandling af cancer | |
| DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK2846809T3 (da) | Behandling af myelosuppression | |
| AR092198A1 (es) | Derivados de pirazolopirimidinas | |
| FI20125146A (fi) | Selluloosamassan esikäsittelymenetelmä | |
| DK2814849T3 (da) | Fremgangsmåde til fremstilling af cyclodextrin-derivater | |
| DK2785349T3 (da) | Kombinationsbehandling af cancer | |
| CO6890099A2 (es) | Nuevos derivados dihidroquinolina-2-ona | |
| DK2717941T3 (da) | Behandling af cancer | |
| DK2701733T3 (da) | Forbindelser til behandling af neuropsykiatriske forstyrrelser | |
| DK2903967T3 (da) | Acylaminopyrimidinderivater til behandling af virusinfektioner og yderligere sygdomme | |
| DK2668967T3 (da) | Implantat | |
| CO7020919A2 (es) | Derivados de tetrahidro-quinazolinona | |
| DK3581199T3 (da) | Fremgangsmåder til behandling eller reduktion af ødematøs fibrosklerotisk pannikulitis | |
| DK2838907T3 (da) | Aminosteroider til behandlingen af en ptp1b-associeret sygdom | |
| CO6960557A2 (es) | Derivados de 2-yodo-imidazol | |
| BR112014009319A2 (pt) | compostos farmacêuticos |